Drawing for NEUROCLUES : THE BRAIN STETHOSCOPE

USPTO serial 79438618

NEUROCLUES : THE BRAIN STETHOSCOPE

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
HALL, MICHAEL E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEUROCLUES : THE BRAIN STETHOSCOPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Benjamin M. Cantor

Benjamin M. Cantor Cantor Colburn LLP20 Church StreetFloor 22Hartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for ophthalmological use; diagnostic preparations for medical or veterinary use; diagnostic preparations for medical use; antiserums being diagnostic preparations for medical use, not for use in diagnosing diseases of the brain; diagnostic agents for medical use, not for use in diagnosing diseases of the brain; diagnostic agents for pharmaceutical use, not for use in diagnosing diseases of the brain; clinical diagnostic reagents for medical use, not for use in diagnosing diseases of the brain; reagents for medical diagnosis, not for use in diagnosing diseases of the brain; chemical preparations for medical use for ophthalmological use, not for use in diagnosing or treating diseases of the brain; dermatological pharmaceutical products; pharmaceutical products for ophthalmological use, not for use in diagnosing or treating diseases of the brain; chemico-pharmaceutical products for ophthalmological use, not for use in diagnosing or treating diseases of the brain; ophthalmic topical anti-infective substances; diagnostic biomarking reagents for medical use, not for use in diagnosing or treating diseases of the brain; Testing and diagnostic products and materials for medical or veterinary use, namely, diagnostic test reagents for medical use, not for use in diagnosing or treating diseases of the brainACTIVE—
009Contact lenses; optical semiconductor amplifiers; lasers for non-medical purposes; optical inspection apparatus for industrial use; target tracking apparatus, namely, optical lens sights; target tracking apparatus, namely, telescopic lens sights; apparatus and instruments for physics, namely, optical sensors; optical apparatus and instruments, namely, optical reflectors; eyewear; optical filters; filters for optical glass; teaching and instructional apparatus, namely, eye-tracking apparatus; biometric identification apparatus; ultrasonic imaging apparatus for scientific use, excluding electronic monitoring devices intended for translating brain activity into sound waves or for monitoring brain activity; telescopes; ultramicroscopes; glassware for laboratories; glassware for scientific experiments in laboratories designed for this use; optical lenses; devices, instruments and cables for electricity, namely, electric cables; optical correctors, amplifiers and devices, namely, optical shutters; residual light image amplifiers; thermal imaging apparatus, other than for medical use; stereoscopic apparatus, namely, stereoscopes; observation instruments in the nature of cameras, excluding electronic monitoring devices intended for translating brain activity into sound waves or for monitoring brain activity or devices intended to monitor brain injuries; computer interfaces; communication interface units, namely, computer interface boards; downloadable graphical user interface software; downloadable software intended for use as an application programming interface (API), unrelated to brain activity monitoringACTIVE—
010Ophthalmologic instruments, namely, eye testing apparatus; therapeutic instruments for ophthalmology, namely, sensors for medical use to gather biometric data; pharmaceutical instruments in the nature of eye-tracking instruments, excluding electronic monitoring devices intended for translating brain activity into sound waves or for monitoring brain activity; pupillometers for measuring the spacing of pupils; pupillometers for measuring the reactivity of eyes for stimulation; medical neurography apparatus in the nature of eye-tracking instruments, excluding electronic monitoring devices intended for translating brain activity into sound waves or for monitoring brain activityACTIVE—
042Providing temporary use of online non-downloadable software for data transmission; providing temporary use of online non-downloadable software for accessing a computer network in the cloud; providing temporary use of online non-downloadable software for accessing a cloud computer network; none of the aforementioned services relating to brain activity monitoring or translating brain activity into sound waves or involving diagnosis or treatment of diseases of the brainACTIVE—
044Pharmaceutical advice; pharmaceutical services, namely, pharmaceutical compounding services; medical services; carrying out disease diagnoses; medical diagnosis services; ophthalmology services; none of the aforementioned services relating to brain activity monitoring or translating brain activity into sound waves or involving diagnosis or treatment of diseases of the brainACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 30, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 30, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 30, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 29, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 29, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 29, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 26, 2026RFNTREFUSAL PROCESSED BY IB—
Mar 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 6, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 5, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2026DOCKASSIGNED TO EXAMINER—
Jan 29, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 30, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 30, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 4, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance